PRO-DEX, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
PRO-DEX, INC. (PDEX) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $1.98 million for the 12-month period ending 2023-06-30, per its 10-K filed 2023-10-13.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2023-10-13
- PRO-DEX, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $1.98M, a 67.29% increase from fiscal 2022.
- PRO-DEX, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was $1.18M, a 0.17% increase from fiscal 2021.
- PRO-DEX, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2021 was $1.18M, a 28.81% decline from fiscal 2020.
- PRO-DEX, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2020 was $1.66M, a 46.17% increase from fiscal 2019.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2023-06-30 | $1.98M 10-K · filed 2023-10-13 | |
| 2022-06-30 | $1.18M 10-K · filed 2023-10-13 | $976.00K 10-K · filed 2022-09-08 |
| 2021-06-30 | $1.18M 10-K · filed 2022-09-08 | |
| 2020-06-30 | $1.66M 10-K · filed 2021-09-09 | |
| 2019-06-30 | $1.14M 10-K · filed 2020-09-10 | |
| 2018-06-30 | $719.00K 10-K · filed 2019-09-12 | |
| 2017-06-30 | $936.00K 10-K · filed 2018-09-13 | |
| 2016-06-30 | $384.00K 10-K · filed 2017-09-14 | $288.00K 10-K · filed 2016-09-15 |
| 2015-06-30 | -$152.00K 10-K · filed 2016-09-15 | $152.00K 10-K · filed 2015-09-17 |
| 2014-06-30 | $257.00K 10-K · filed 2015-09-17 | |
| 2013-06-30 | $647.00K 10-K · filed 2014-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |